Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
SEM's Cash to Debt is ranked lower than
98% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. SEM: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
SEM' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.06
Current: 0.01
0
0.06
Equity to Asset 0.19
SEM's Equity to Asset is ranked lower than
84% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. SEM: 0.19 )
Ranked among companies with meaningful Equity to Asset only.
SEM' s Equity to Asset Range Over the Past 10 Years
Min: -0.11  Med: 0.25 Max: 0.3
Current: 0.19
-0.11
0.3
Interest Coverage 2.44
SEM's Interest Coverage is ranked lower than
76% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 6.25 vs. SEM: 2.44 )
Ranked among companies with meaningful Interest Coverage only.
SEM' s Interest Coverage Range Over the Past 10 Years
Min: 1.35  Med: 2.27 Max: 3.55
Current: 2.44
1.35
3.55
F-Score: 6
Z-Score: 1.52
M-Score: -2.23
WACC vs ROIC
7.46%
6.31%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.34
SEM's Operating margin (%) is ranked lower than
51% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. SEM: 7.34 )
Ranked among companies with meaningful Operating margin (%) only.
SEM' s Operating margin (%) Range Over the Past 10 Years
Min: 7.34  Med: 10.01 Max: 13.93
Current: 7.34
7.34
13.93
Net-margin (%) 3.49
SEM's Net-margin (%) is ranked lower than
57% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 4.79 vs. SEM: 3.49 )
Ranked among companies with meaningful Net-margin (%) only.
SEM' s Net-margin (%) Range Over the Past 10 Years
Min: 1.04  Med: 3.67 Max: 5.12
Current: 3.49
1.04
5.12
ROE (%) 15.88
SEM's ROE (%) is ranked higher than
72% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.90 vs. SEM: 15.88 )
Ranked among companies with meaningful ROE (%) only.
SEM' s ROE (%) Range Over the Past 10 Years
Min: 10.2  Med: 15.37 Max: 19.74
Current: 15.88
10.2
19.74
ROA (%) 3.44
SEM's ROA (%) is ranked lower than
52% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. SEM: 3.44 )
Ranked among companies with meaningful ROA (%) only.
SEM' s ROA (%) Range Over the Past 10 Years
Min: 0.88  Med: 3.75 Max: 5.36
Current: 3.44
0.88
5.36
ROC (Joel Greenblatt) (%) 34.65
SEM's ROC (Joel Greenblatt) (%) is ranked higher than
70% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 17.56 vs. SEM: 34.65 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SEM' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 35.14  Med: 44.82 Max: 75.33
Current: 34.65
35.14
75.33
Revenue Growth (3Y)(%) 11.40
SEM's Revenue Growth (3Y)(%) is ranked higher than
68% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. SEM: 11.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SEM' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 0.90 Max: 13.1
Current: 11.4
0
13.1
EBITDA Growth (3Y)(%) 4.90
SEM's EBITDA Growth (3Y)(%) is ranked lower than
65% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. SEM: 4.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SEM' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -1.55 Max: 12.9
Current: 4.9
0
12.9
EPS Growth (3Y)(%) -1.80
SEM's EPS Growth (3Y)(%) is ranked lower than
75% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. SEM: -1.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SEM' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 8.20 Max: 99.9
Current: -1.8
0
99.9
» SEM's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-07)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

SEM Guru Trades in Q2 2015

Ken Fisher 3,862,249 sh (+80.31%)
David Dreman 767,655 sh (+9.27%)
Chuck Royce 137,500 sh (-31.25%)
Paul Tudor Jones 16,900 sh (-35.50%)
» More
Q3 2015

SEM Guru Trades in Q3 2015

Jim Simons 160,322 sh (New)
Paul Tudor Jones 47,900 sh (+183.43%)
Chuck Royce 164,000 sh (+19.27%)
David Dreman 876,534 sh (+14.18%)
Ken Fisher 3,908,019 sh (+1.19%)
» More
Q4 2015

SEM Guru Trades in Q4 2015

Louis Moore Bacon 481,000 sh (New)
Steven Cohen 851,200 sh (New)
Ken Fisher 4,808,730 sh (+23.05%)
Chuck Royce 190,000 sh (+15.85%)
George Soros 307,500 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
David Dreman 830,862 sh (-5.21%)
» More
Q1 2016

SEM Guru Trades in Q1 2016

Ken Fisher 4,808,263 sh (-0.01%)
» More
» Details

Insider Trades

Latest Guru Trades with SEM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 13.47
SEM's P/E(ttm) is ranked higher than
83% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. SEM: 13.47 )
Ranked among companies with meaningful P/E(ttm) only.
SEM' s P/E(ttm) Range Over the Past 10 Years
Min: 7.73  Med: 13.87 Max: 24.61
Current: 13.47
7.73
24.61
Forward P/E 13.76
SEM's Forward P/E is ranked higher than
70% of the 74 Companies
in the Global Medical Care industry.

( Industry Median: 16.81 vs. SEM: 13.76 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 13.09
SEM's PE(NRI) is ranked higher than
86% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. SEM: 13.09 )
Ranked among companies with meaningful PE(NRI) only.
SEM' s PE(NRI) Range Over the Past 10 Years
Min: 7.5  Med: 13.70 Max: 21.47
Current: 13.09
7.5
21.47
Price/Owner Earnings (ttm) 17.56
SEM's Price/Owner Earnings (ttm) is ranked higher than
70% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 26.24 vs. SEM: 17.56 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
SEM' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.2  Med: 18.55 Max: 490.53
Current: 17.56
6.2
490.53
P/B 2.03
SEM's P/B is ranked higher than
62% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. SEM: 2.03 )
Ranked among companies with meaningful P/B only.
SEM' s P/B Range Over the Past 10 Years
Min: 1.09  Med: 1.70 Max: 2.87
Current: 2.03
1.09
2.87
P/S 0.44
SEM's P/S is ranked higher than
83% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.56 vs. SEM: 0.44 )
Ranked among companies with meaningful P/S only.
SEM' s P/S Range Over the Past 10 Years
Min: 0.24  Med: 0.45 Max: 0.7
Current: 0.44
0.24
0.7
PFCF 64.48
SEM's PFCF is ranked lower than
83% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 21.39 vs. SEM: 64.48 )
Ranked among companies with meaningful PFCF only.
SEM' s PFCF Range Over the Past 10 Years
Min: 4.49  Med: 8.77 Max: 66.9
Current: 64.48
4.49
66.9
POCF 8.02
SEM's POCF is ranked higher than
74% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.93 vs. SEM: 8.02 )
Ranked among companies with meaningful POCF only.
SEM' s POCF Range Over the Past 10 Years
Min: 3.11  Med: 6.02 Max: 11.08
Current: 8.02
3.11
11.08
EV-to-EBIT 13.14
SEM's EV-to-EBIT is ranked higher than
75% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 19.52 vs. SEM: 13.14 )
Ranked among companies with meaningful EV-to-EBIT only.
SEM' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.9  Med: 10.50 Max: 15.4
Current: 13.14
7.9
15.4
EV-to-EBITDA 9.85
SEM's EV-to-EBITDA is ranked higher than
72% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 13.44 vs. SEM: 9.85 )
Ranked among companies with meaningful EV-to-EBITDA only.
SEM' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 8.30 Max: 12.3
Current: 9.85
6.2
12.3
PEG 1.43
SEM's PEG is ranked higher than
72% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. SEM: 1.43 )
Ranked among companies with meaningful PEG only.
SEM' s PEG Range Over the Past 10 Years
Min: 0.5  Med: 1.53 Max: 8.7
Current: 1.43
0.5
8.7
Shiller P/E 18.01
SEM's Shiller P/E is ranked higher than
73% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 30.32 vs. SEM: 18.01 )
Ranked among companies with meaningful Shiller P/E only.
SEM' s Shiller P/E Range Over the Past 10 Years
Min: 10.27  Med: 15.45 Max: 18.6
Current: 18.01
10.27
18.6
Current Ratio 1.02
SEM's Current Ratio is ranked lower than
66% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.36 vs. SEM: 1.02 )
Ranked among companies with meaningful Current Ratio only.
SEM' s Current Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.22 Max: 1.52
Current: 1.02
0.86
1.52
Quick Ratio 1.02
SEM's Quick Ratio is ranked lower than
61% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. SEM: 1.02 )
Ranked among companies with meaningful Quick Ratio only.
SEM' s Quick Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.22 Max: 1.52
Current: 1.02
0.86
1.52
Days Sales Outstanding 58.86
SEM's Days Sales Outstanding is ranked lower than
72% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 44.25 vs. SEM: 58.86 )
Ranked among companies with meaningful Days Sales Outstanding only.
SEM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.41  Med: 51.48 Max: 58.86
Current: 58.86
39.41
58.86
Days Payable 15.62
SEM's Days Payable is ranked lower than
83% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 42.56 vs. SEM: 15.62 )
Ranked among companies with meaningful Days Payable only.
SEM' s Days Payable Range Over the Past 10 Years
Min: 12.91  Med: 14.95 Max: 17.85
Current: 15.62
12.91
17.85

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.70
SEM's Price/Projected FCF is ranked higher than
88% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. SEM: 0.70 )
Ranked among companies with meaningful Price/Projected FCF only.
SEM' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.64  Med: 0.88 Max: 1
Current: 0.7
0.64
1
Price/Median PS Value 0.99
SEM's Price/Median PS Value is ranked higher than
56% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. SEM: 0.99 )
Ranked among companies with meaningful Price/Median PS Value only.
SEM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.7  Med: 1.00 Max: 1.36
Current: 0.99
0.7
1.36
Price/Peter Lynch Fair Value 1.58
SEM's Price/Peter Lynch Fair Value is ranked higher than
67% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 2.21 vs. SEM: 1.58 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SEM' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.52  Med: 0.98 Max: 1.44
Current: 1.58
0.52
1.44
Earnings Yield (Greenblatt) (%) 7.66
SEM's Earnings Yield (Greenblatt) (%) is ranked higher than
80% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. SEM: 7.66 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SEM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.5  Med: 9.50 Max: 12.7
Current: 7.66
6.5
12.7
Forward Rate of Return (Yacktman) (%) 14.93
SEM's Forward Rate of Return (Yacktman) (%) is ranked higher than
64% of the 102 Companies
in the Global Medical Care industry.

( Industry Median: 11.10 vs. SEM: 14.93 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SEM' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -3.3  Med: 9.90 Max: 30.1
Current: 14.93
-3.3
30.1

More Statistics

Revenue(Mil) $3743
EPS $ 0.97
Beta1.34
Short Percentage of Float11.58%
52-Week Range $7.33 - 17.20
Shares Outstanding(Mil)131.28

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 4,166 4,363 4,610
EPS($) 0.85 0.95 1.01
EPS without NRI($) 0.85 0.95 1.01

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:LPNT, LSE:NMC, BOM:508869, JSE:LHC, NYSE:CHE, NYSE:CYH » details
Traded in other countries:S24.Germany,
Select Medical Holdings Corp was formed in December 1996. The Company provides long term acute care hospital services and inpatient acute rehabilitative hospital care through its specialty hospital segment and provides physical, occupational and speech rehabilitation services through its outpatient rehabilitation segment. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. The Company's specialty hospital segment consists of hospitals designed to serve the needs of long term stay acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. Patients are admitted to the Company's specialty hospitals from general acute care hospitals. These patients have specialized needs, and serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders and cancer. The Company's outpatient rehabilitation segment consists of clinics and contract services that provide physical, occupational and speech rehabilitation services. The Company's outpatient rehabilitation patients are diagnosed with musculoskeletal impairments that restrict their ability to perform normal activities of daily living. As of December 31, 2013, the Company operated 123 specialty hospitals in 28 states, and 1,006 outpatient rehabilitation clinics in 32 states and the District of Columbia. It also provide medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites. The Company competes with Kindred Healthcare Inc., HealthSouth Corporation, Physiotherapy Associates and U.S. Physical Therapy among others. Its healthcare facilities are subject to state and local licensing regulations.
» More Articles for SEM

Headlines

Articles On GuruFocus.com
What Could Be Dresser-Rand’s Future? Sep 23 2014 

More From Other Websites
May 5, 2016 - Select Medical Holdings Corporation Announces Results for First Quarter Ended March... May 05 2016
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2016
SELECT MEDICAL HOLDINGS CORP Files SEC form 10-Q, Quarterly Report May 05 2016
4:49 pm Select Medical beats by $0.04, beats on revs; guides FY16 EPS above consensus, revs in-line May 05 2016
Select Medical Holdings Corporation Announces Results for First Quarter Ended March 31, 2016 May 05 2016
5 May, 2016 | Acções Próprias May 05 2016
Q1 2016 Select Medical Holdings Corp Earnings Release - After Market Close May 05 2016
29 April, 2016 | Privileged Information - Quarterly Results Apr 29 2016
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Apr 27 2016
26 April, 2016 | Own Shares Apr 26 2016
22 April, 2016 | Payment of Dividends Apr 22 2016
April 21, 2016 - Select Medical Holdings Corporation to Announce First Quarter 2016 Results on... Apr 21 2016
Select Medical Holdings Corporation to Announce First Quarter 2016 Results on Thursday, May 5 Apr 21 2016
20 April, 2016 | Privileged Information - Annual General Meeting Apr 20 2016
20 April, 2016 | Company Bodies Apr 20 2016
13 April, 2016 | Own Shares Apr 13 2016
8 April, 2016 | Own Shares Apr 08 2016
Select Medical Holdings Corporation Announces Sale of its Contract Therapy Business Apr 01 2016
Select Medical Sells Contract Therapy Unit to Enhance Profile Apr 01 2016
1 April, 2016 | Annual Acounts Apr 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK